The 4 analysts offering 1 year price forecasts for 471A have a max estimate of — and a min estimate of —.
Analyst rating
Based on 4 analysts giving stock ratings to 471A in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
471A EPS for the last quarter is −0.21 EUR despite the estimation of −0.23 EUR. In the next quarter EPS is expected to reach −0.21 EUR. Track more of ATYR PHARMA INC financials and stay on top of what is up with the company.
In the next quarter ATYR PHARMA INC revenue is expected to reach 36.85 K EUR. Check out ATYR PHARMA INC revenue and earnings and make informed decisions.
According to analysts, 471A price target is 23.26 EUR with a max estimate of 32.24 EUR and a min estimate of 14.74 EUR. Check if this forecast comes true in a year, meanwhile watch ATYR PHARMA INC stock price chart and keep track of the current situation with 471A news and stock market news.